MCT – triglyceridy so stredným reťazcom

Literatúra

  1. Babayan V. Medium chain length fatty acid esters and their medical and nutritional applications. J Am Oil Chem Soc. (1981)
  2. Sigalet DL, Martin G. Lymphatic absorption of glucose and fatty acids as determined by direct measurement. J Pediatr Surg. (1999)
  3. Sigalet DL, Winkelaar GB, Smith LJ. Determination of the route of medium-chain and long-chain fatty acid absorption by direct measurement in the rat. JPEN J Parenter Enteral Nutr. (1997)
  4. USDA Food Composition Database Nutrient list for C6:0, C8:0, and C10:0.
  5. Bach AC, Babayan VK. Medium-chain triglycerides: an update. Am J Clin Nutr. (1982)
  6. Ghosh S, Bhattacharyya DK. Medium-chain fatty acid-rich glycerides by chemical and lipase-catalyzed polyester-monoester interchange reaction. J Amer Oil Chem Soc. (1997)
  7. Mu H, Porsgaard T. The metabolism of structured triacylglycerols. Prog Lipid Res. (2005)
  8. Mansbach CM 2nd, Gorelick F. Development and physiological regulation of intestinal lipid absorption. II. Dietary lipid absorption, complex lipid synthesis, and the intracellular packaging and secretion of chylomicrons. Am J Physiol Gastrointest Liver Physiol. (2007)
  9. McLaughlin J, et al. Fatty acid chain length determines cholecystokinin secretion and effect on human gastric motility. Gastroenterology. (1999)
  10. Symersky T, et al. The effect of equicaloric medium-chain and long-chain triglycerides on pancreas enzyme secretion. Clin Physiol Funct Imaging. (2002)
  11. You YQ, et al. Effects of medium-chain triglycerides, long-chain triglycerides, or 2-monododecanoin on fatty acid composition in the portal vein, intestinal lymph, and systemic circulation in rats. JPEN J Parenter Enteral Nutr. (2008)
  12. Iber FL. Relative rates of metabolism MCT, LCT and ethanol in man. Z Ernahrungswiss Suppl. (1974)
  13. Borel P, et al. Chylomicron beta-carotene and retinyl palmitate responses are dramatically diminished when men ingest beta-carotene with medium-chain rather than long-chain triglycerides. J Nutr. (1998)
  14. Swift LL, et al. Medium-chain fatty acids: evidence for incorporation into chylomicron triglycerides in humans. Am J Clin Nutr. (1990)
  15. Rubio-Gozalbo ME, et al. Carnitine-acylcarnitine translocase deficiency, clinical, biochemical and genetic aspects. Mol Aspects Med. (2004)
  16. Bach A, Phan T, Metais P. Effect of the fatty acid composition of ingested fats on rat liver intermediary metabolism. Horm Metab Res. (1976)
  17. Bach A. Oxaloacetate deficiency in MCT-induced ketogenesis. Arch Int Physiol Biochim. (1978)
  18. McGarry JD, Foster DW. Regulation of hepatic fatty acid oxidation and ketone body production. Annu Rev Biochem. (1980)
  19. Yeh YY, Zee P. Relation of ketosis to metabolic changes induced by acute medium-chain triglyceride feeding in rats. J Nutr. (1976)
  20. Bach A, et al. Ketogenic response to medium-chain triglyceride load in the rat. J Nutr. (1977)
  21. McGarry JD, Foster DW. The regulation of ketogenesis from octanoic acid. The role of the tricarboxylic acid cycle and fatty acid synthesis. J Biol Chem. (1971)
  22. Vandenberghe C, et al. Tricaprylin alone increases plasma ketone response more than coconut oil or other medium chain triglycerides: an acute crossover study in healthy adults. Curr Dev Nutr. (2017)
  23. Adkison KD, Shen DD. Uptake of valproic acid into rat brain is mediated by a medium-chain fatty acid transporter. J Pharmacol Exp Ther. (1996)
  24. Chang P, et al. Seizure control by decanoic acid through direct AMPA receptor inhibition. Brain. (2016)
  25. Van Wymelbeke V, Louis-Sylvestre J, Fantino M. Substrate oxidation and control of food intake in men after a fat-substitute meal compared with meals supplemented with an isoenergetic load of carbohydrate, long-chain triacylglycerols, or medium-chain triacylglycerols. Am J Clin Nutr. (2001)
  26. Rolls BJ, et al. Food intake in dieters and nondieters after a liquid meal containing medium-chain triglycerides. Am J Clin Nutr. (1988)
  27. St-Onge MP, et al. Impact of medium and long chain triglycerides consumption on appetite and food intake in overweight men. Eur J Clin Nutr. (2014)
  28. Van Wymelbeke V, et al. Influence of medium-chain and long-chain triacylglycerols on the control of food intake in men. Am J Clin Nutr. (1998)
  29. Stubbs RJ, Harbron CG. Covert manipulation of the ratio of medium- to long-chain triglycerides in isoenergetically dense diets: effect on food intake in ad libitum feeding men. Int J Obes Relat Metab Disord. (1996)
  30. Krotkiewski M. Value of VLCD supplementation with medium chain triglycerides. Int J Obes Relat Metab Disord. (2001)
  31. Han JR, et al. Effects of dietary medium-chain triglyceride on weight loss and insulin sensitivity in a group of moderately overweight free-living type 2 diabetic Chinese subjects. Metabolism. (2007)
  32. Martin K, et al. Ketogenic diet and other dietary treatments for epilepsy. Cochrane Database Syst Rev. (2016)
  33. Lima PA, Sampaio LP, Damasceno NR. Neurobiochemical mechanisms of a ketogenic diet in refractory epilepsy. Clinics (Sao Paulo). (2014)
  34. Masino SA, Rho JM. Mechanisms of Ketogenic Diet Action.
  35. Groleau V, et al. Long-term impact of the ketogenic diet on growth and resting energy expenditure in children with intractable epilepsy. Dev Med Child Neurol. (2014)
  36. Bergqvist AG, et al. Progressive bone mineral content loss in children with intractable epilepsy treated with the ketogenic diet. Am J Clin Nutr. (2008)
  37. Huttenlocher PR, Wilbourn AJ, Signore JM. Medium-chain triglycerides as a therapy for intractable childhood epilepsy. Neurology. (1971)
  38. Huttenlocher PR. Ketonemia and seizures: metabolic and anticonvulsant effects of two ketogenic diets in childhood epilepsy. Pediatr Res. (1976)
  39. Trauner DA. Medium-chain triglyceride (MCT) diet in intractable seizure disorders. Neurology. (1985)
  40. Sills MA, et al. The medium chain triglyceride diet and intractable epilepsy. Arch Dis Child. (1986)
  41. Schwartz RH, et al. Ketogenic diets in the treatment of epilepsy: short-term clinical effects. Dev Med Child Neurol. (1989)
  42. Schwartz RM, Boyes S, Aynsley-Green A. Metabolic effects of three ketogenic diets in the treatment of severe epilepsy. Dev Med Child Neurol. (1989)
  43. Liu YM. Medium-chain triglyceride (MCT) ketogenic therapy. Epilepsia. (2008)
  44. Liu YM, Wang HS. Medium-chain triglyceride ketogenic diet, an effective treatment for drug-resistant epilepsy and a comparison with other ketogenic diets. Biomed J. (2013)
  45. Neal EG, et al. Growth of children on classical and medium-chain triglyceride ketogenic diets. Pediatrics. (2008)
  46. Neal EG, et al. A randomized trial of classical and medium-chain triglyceride ketogenic diets in the treatment of childhood epilepsy. Epilepsia. (2009)
  47. Azzam R, Azar NJ. Marked Seizure Reduction after MCT Supplementation. Case Rep Neurol Med. (2013)
  48. Reger MA, et al. Effects of beta-hydroxybutyrate on cognition in memory-impaired adults. Neurobiol Aging. (2004)
  49. Henderson ST, et al. Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer’s disease: a randomized, double-blind, placebo-controlled, multicenter trial. Nutr Metab (Lond). (2009)
  50. Rebello CJ, et al. Pilot feasibility and safety study examining the effect of medium chain triglyceride supplementation in subjects with mild cognitive impairment: A randomized controlled trial. BBA Clin. (2015)
  51. Cunnane SC, et al. Can Ketones Help Rescue Brain Fuel Supply in Later Life? Implications for Cognitive Health during Aging and the Treatment of Alzheimer’s Disease. Front Mol Neurosci. (2016)
  52. Tsuji H, et al. Dietary medium-chain triacylglycerols suppress accumulation of body fat in a double-blind, controlled trial in healthy men and women. J Nutr. (2001)
  53. Tsai YH, et al. Mechanisms mediating lipoprotein responses to diets with medium-chain triglyceride and lauric acid. Lipids. (1999)
  54. Temme EH, Mensink RP, Hornstra G. Effects of medium chain fatty acids (MCFA), myristic acid, and oleic acid on serum lipoproteins in healthy subjects. J Lipid Res. (1997)
  55. Swift LL, et al. Plasma lipids and lipoproteins during 6 d of maintenance feeding with long-chain, medium-chain, and mixed-chain triglycerides. Am J Clin Nutr. (1992)
  56. Hill JO, et al. Changes in blood lipids during six days of overfeeding with medium or long chain triglycerides. J Lipid Res. (1990)
  57. HASHIM SA, ARTEAGA A, VAN ITALLIE TB. Effect of a saturated medium-chain triglyceride on serum-lipids in man. Lancet. (1960)
  58. St-Onge MP, et al. Medium chain triglyceride oil consumption as part of a weight loss diet does not lead to an adverse metabolic profile when compared to olive oil. J Am Coll Nutr. (2008)
  59. Tremblay AJ, et al. Dietary medium-chain triglyceride supplementation has no effect on apolipoprotein B-48 and apolipoprotein B-100 kinetics in insulin-resistant men. Am J Clin Nutr. (2014)
  60. van Schalkwijk DB, et al. Dietary medium chain fatty acid supplementation leads to reduced VLDL lipolysis and uptake rates in comparison to linoleic acid supplementation. PLoS One. (2014)
  61. Turkenkopf IJ, Maggio CA, Greenwood MR. Effect of high fat weanling diets containing either medium-chain triglycerides or long-chain triglycerides on the development of obesity in the Zucker rat. J Nutr. (1982)
  62. Kasai M, et al. Effect of dietary medium- and long-chain triacylglycerols (MLCT) on accumulation of body fat in healthy humans. Asia Pac J Clin Nutr. (2003)
  63. Xue C, et al. Consumption of medium- and long-chain triacylglycerols decreases body fat and blood triglyceride in Chinese hypertriglyceridemic subjects. Eur J Clin Nutr. (2009)
  64. Zhang YH, et al. Medium- and long-chain fatty acid triacylglycerol reduce body fat and serum triglyceride in overweight and hypertriglyceridemic subjects. Zhonghua Yu Fang Yi Xue Za Zhi. (2009)
  65. Liu Y, et al. A good response to oil with medium- and long-chain fatty acids in body fat and blood lipid profiles of male hypertriglyceridemic subjects. Asia Pac J Clin Nutr. (2009)
  66. Barrett-Connor E. Sex differences in coronary heart disease. Why are women so superior? The 1995 Ancel Keys Lecture. Circulation. (1997)
  67. Zhang Y, et al. Medium- and long-chain triacylglycerols reduce body fat and blood triacylglycerols in hypertriacylglycerolemic, overweight but not obese, Chinese individuals. Lipids. (2010)
  68. Asakura L, et al. Dietary medium-chain triacylglycerol prevents the postprandial rise of plasma triacylglycerols but induces hypercholesterolemia in primary hypertriglyceridemic subjects. Am J Clin Nutr. (2000)
  69. Cater NB, Heller HJ, Denke MA. Comparison of the effects of medium-chain triacylglycerols, palm oil, and high oleic acid sunflower oil on plasma triacylglycerol fatty acids and lipid and lipoprotein concentrations in humans. Am J Clin Nutr. (1997)
  70. UZAWA H, et al. HYPERGLYCERIDEMIA RESULTING FROM INTAKE OF MEDIUM CHAIN TRIGLYCERIDES. Am J Clin Nutr. (1964)
  71. Eckel RH, et al. Dietary substitution of medium-chain triglycerides improves insulin-mediated glucose metabolism in NIDDM subjects. Diabetes. (1992)
  72. Airhart S, et al. A Diet Rich in Medium-Chain Fatty Acids Improves Systolic Function and Alters the Lipidomic Profile in Patients With Type 2 Diabetes: A Pilot Study. J Clin Endocrinol Metab. (2016)
  73. Hayes KC. Medium-chain triacylglycerols may not raise cholesterol. Am J Clin Nutr. (2000)
  74. Pi-Sunyer FX, Hashim SA, Van Itallie TB. Insulin and ketone responses to ingestion of medium and long-chain triglycerides in man. Diabetes. (1969)
  75. Tamir I, et al. Effects of a single oral load of medium-chain triglyceride on serum lipid and insulin levels in man. J Lipid Res. (1968)
  76. Yost TJ, et al. Dietary substitution of medium chain triglycerides in subjects with non-insulin-dependent diabetes mellitus in an ambulatory setting: impact on glycemic control and insulin-mediated glucose metabolism. J Am Coll Nutr. (1994)
  77. Souza PF, Williamson DH. Effects of feeding medium-chain triacylglycerols on maternal lipid metabolism and pup growth in lactating rats. Br J Nutr. (1993)
  78. Lieber CS, et al. Difference in hepatic metabolism of long- and medium-chain fatty acids: the role of fatty acid chain length in the production of the alcoholic fatty liver. J Clin Invest. (1967)
  79. Johnson RC, et al. Medium-chain-triglyceride lipid emulsion: metabolism and tissue distribution. Am J Clin Nutr. (1990)
  80. Watkins JB, et al. Diagnosis and differentiation of fat malabsorption in children using 13C-labeled lipids: trioctanoin, triolein, and palmitic acid breath tests. Gastroenterology. (1982)
  81. Metges CC, Wolfram G. Medium- and long-chain triglycerides labeled with 13C: a comparison of oxidation after oral or parenteral administration in humans. J Nutr. (1991)
  82. Schoeller DA, et al. 13C abundances of nutrients and the effect of variations in 13C isotopic abundances of test meals formulated for 13CO2 breath tests. Am J Clin Nutr. (1980)
  83. Papamandjaris AA, et al. Endogenous fat oxidation during medium chain versus long chain triglyceride feeding in healthy women. Int J Obes Relat Metab Disord. (2000)
  84. Binnert C, et al. Influence of human obesity on the metabolic fate of dietary long- and medium-chain triacylglycerols. Am J Clin Nutr. (1998)
  85. Carnitine Palmitoyltransferase 1A Deficiency.
  86. Geliebter A, et al. Overfeeding with medium-chain triglyceride diet results in diminished deposition of fat. Am J Clin Nutr. (1983)
  87. Dulloo AG, et al. Differential effects of high-fat diets varying in fatty acid composition on the efficiency of lean and fat tissue deposition during weight recovery after low food intake. Metabolism. (1995)
  88. Crozier G, et al. Metabolic effects induced by long-term feeding of medium-chain triglycerides in the rat. Metabolism. (1987)
  89. Lavau MM, Hashim SA. Effect of medium chain triglyceride on lipogenesis and body fat in the rat. J Nutr. (1978)
  90. Papamandjaris AA, White MD, Jones PJ. Components of total energy expenditure in healthy young women are not affected after 14 days of feeding with medium-versus long-chain triglycerides. Obes Res. (1999)
  91. Roynette CE, et al. Structured medium and long chain triglycerides show short-term increases in fat oxidation, but no changes in adiposity in men. Nutr Metab Cardiovasc Dis. (2008)
  92. Assunção ML, et al. Effects of dietary coconut oil on the biochemical and anthropometric profiles of women presenting abdominal obesity. Lipids. (2009)
  93. Clegg ME. Medium-chain triglycerides are advantageous in promoting weight loss although not beneficial to exercise performance. Int J Food Sci Nutr. (2010)
  94. Does medium chain triglyceride play an ergogenic role in endurance exercise performance?.
  95. Hawley JA, Brouns F, Jeukendrup A. Strategies to enhance fat utilisation during exercise. Sports Med. (1998)
  96. Horowitz JF, et al. Preexercise medium-chain triglyceride ingestion does not alter muscle glycogen use during exercise. J Appl Physiol. (2000)
  97. Misell LM, et al. Chronic medium-chain triacylglycerol consumption and endurance performance in trained runners. J Sports Med Phys Fitness. (2001)
  98. Goedecke JH, et al. The effects of medium-chain triacylglycerol and carbohydrate ingestion on ultra-endurance exercise performance. Int J Sport Nutr Exerc Metab. (2005)
  99. Angus DJ, et al. Effect of carbohydrate or carbohydrate plus medium-chain triglyceride ingestion on cycling time trial performance. J Appl Physiol. (2000)
  100. Kehayoglou K, et al. The effect of medium-chain triglyceride on 47 calcium absorption in patients with primary biliary cirrhosis. Gut. (1973)
  101. Harrison JE, et al. Effect of medium chain triglyceride on fecal calcium losses in pancreatic insufficiency. Clin Biochem. (1973)
  102. Tandon RK, Rodgers JB Jr, Balint JA. The effects of medium-chain triglycerides in the short bowel syndrome. Increased glucose and water transport. Am J Dig Dis. (1972)
  103. Traul KA, et al. Review of the toxicologic properties of medium-chain triglycerides. Food Chem Toxicol. (2000)
  104. Nair AB, Jacob S. A simple practice guide for dose conversion between animals and human. J Basic Clin Pharm. (2016)
  105. White MD, Papamandjaris AA, Jones PJ. Enhanced postprandial energy expenditure with medium-chain fatty acid feeding is attenuated after 14 d in premenopausal women. Am J Clin Nutr. (1999)